shadow_tr

Faculty


Nabeel Khan, MDNabeel Khan, MD
Assistant Clinical Professor of Medicine
Director Inflammatory Bowel Disease

Biography

Dr. Khan received his medical degree from King Edwards Medical College in Pakistan. He went on to complete his residency in internal medicine at Mercy Catholic Medical Center in Philadelphia, PA. He completed his fellowship in Gastroenterology from Louisiana State University. He was trained in ERCP’s and has special interest in motility studies. He worked in a private practice group in Memphis, TN and later became an Instructor at SUNY Brooklyn School of Medicine.

Selected Publications

Khan N, Abbas AM, Lichtenstein GR, Loftus EV Jr, Bazzano LA Risk of Lymphoma in Patients with Ulcerative Colitis Treated with Thiopurines-a Nationwide Retrospective Cohort Study. Gastroenterology. 2013 Nov;145 (5):1007-1015.e3. doi: 10.1053/j.gastro.2013.07.035.Epub 2013 Jul 25

Khan N, Abbas AM, Williamson M, Balart L. Prevalence of Corticosteroids Use and Disease Course after Initial Steroid Exposure in Ulcerative Colitis. Dig Dis Sci. 2013 Jun 29. [Epub ahead of print

>Khan N, Abbas AM, Almukhtar RM, Khan A. Prevalence and Predictors of Low Bone Mineral Density in Males with Ulcerative Colitis J Clin Endocrinol Metab. 2013 Apr 17 [Epub ahead of print]

Khan N, Abbas AM, Koleva YN, Bazzano LA. Long Term Mesalamine Maintenance in Ulcerative Colitis: Which is More Important? Adherence or Daily Dose. Inflamm Bowel Dis. 2013 Mar 19. [Epub ahead of print]

Khan N, Abbas AM, Moehlen M, Balart LA. Methotrexate in Ulcerative Colitis: A Nationwide Retrospective Cohort from the Veterans Affairs Healthcare System. Inflamm Bowel Dis. 2013 Mar 29. [Epub ahead of print]

Khan N, Abbas AM, Bazzano LA, Koleva YN, Krousel-Wood M. Long-term oral mesalazine adherence and the risk of disease flare in ulcerative colitis: nationwide 10-year retrospective cohort from the veteran’s affairs healthcare system. Alimentary Pharmacology & Therapeutics. doi: 10.1111/apt.12013. PMID: 22882428

Khan N, Abbas AM, Whang N, Balart LA, Bazzano LA, Kelly TN. Incidence of liver toxicity in inflammatory bowel disease patients treated with methotrexate: A meta-analysis of clinical trials. Inflamm Bowel Dis. 2012 Feb; 18(2):359-67. doi: 10.1002/ibd.21820. Epub 2011 Jul 12. Review. PMID: 21751301

Incidence of liver toxicity in inflammatory bowel disease patients treated with methotrexate: A meta-analysis of clinical trials. Khan N, Abbas AM, Whang N, Balart LA, Bazzano LA, Kelly TN.Inflamm Bowel Dis. 2011 Jul 12. doi: 10.1002/ibd.21820. [Epub ahead of print].

Atypical GERD symptoms are often not due to reflux shown by PH monitor. N. Khan, R. Gideon, P. Katz, D. Castell. American Journal of Gastroenterology, Sep 2000 Supplement (Abstract).

Factors predicting a positive hepatitis panel in a community hospital setting, N. Khan, G. Tadros, S. Singh, J. Abrams, W. Paine. American Journal of Gastroenterology. Sep 2000 Supplement (Abstract).

Multiple liver abscesses due to Yersinia enterocolitica reveal hereditary hemochromatosis. N. Khan, R. Hally, L. Balart. American Journal of Gastroenterology, Sep 2001 Supplement (Abstract).

Low yield of screening for Barrett’s esophagus in patients with a history of gastroesophageal reflux in a university hospital setting. N. Khan, B. Ruiz, L. Balart. American Journal of Gastroenterology, Sep 2002 Supplement(Abstract).

Maintenance therapy with Infliximab in the management of fistulous Crohn’s disease. N. Khan, T. Huynh Le, L. Balart. American Journal of Gastroenterology, Sep 2002 Supplement (Abstract).

 

 

1430 Tulane Ave, New Orleans, LA 70112 504-988-5263 medsch@tulane.edu